1. Home
  2. FHN vs BIO Comparison

FHN vs BIO Comparison

Compare FHN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Horizon Corporation

FHN

First Horizon Corporation

HOLD

Current Price

$24.51

Market Cap

11.0B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$303.72

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHN
BIO
Founded
1864
1952
Country
United States
United States
Employees
N/A
7700
Industry
Major Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FHN
BIO
Price
$24.51
$303.72
Analyst Decision
Buy
Strong Buy
Analyst Count
18
4
Target Price
$24.61
$358.50
AVG Volume (30 Days)
5.5M
155.9K
Earning Date
01-15-2026
02-12-2026
Dividend Yield
2.45%
N/A
EPS Growth
20.88
N/A
EPS
1.65
N/A
Revenue
$3,184,000,000.00
$2,557,500,000.00
Revenue This Year
$10.95
$1.62
Revenue Next Year
$2.82
$2.26
P/E Ratio
$14.81
N/A
Revenue Growth
3.68
N/A
52 Week Low
$15.19
$211.43
52 Week High
$24.75
$373.69

Technical Indicators

Market Signals
Indicator
FHN
BIO
Relative Strength Index (RSI) 72.00 44.66
Support Level $23.54 $298.78
Resistance Level $24.75 $307.07
Average True Range (ATR) 0.42 7.77
MACD 0.07 -0.88
Stochastic Oscillator 87.89 35.90

Price Performance

Historical Comparison
FHN
BIO

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: